We treated the bone marrow mononuclear cells cultured in 3D or conventional system with 30 pg/mL of IL6, which is the average serum concentration found in Stage III myeloma patients [19], every day for 3 days. The gene discussed is IL6; the disease is plasma cell myeloma.